Host: |
HEK293 cells |
Reactivity: |
SARS-CoV-2 |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Recombinant-SARS-CoV-2 Spike S1 (B.1.1.529/Omicron)-C-His protein was developed from hek293 cells and has a target region of C-His. For use in research applications. |
Formulation: |
Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Immunoreactivity: |
Immobilized Human ACE2, hFc Tag at 2 Mu g/ml (100 Mu l/well) on the plate. Dose response curve for SARS-COV-2 Spike S1 (Omicron B.1.1.529) , His Tag with the EC50 of 0.8 Mu g/ml determined by ELISA. |
Immunogen Region: |
Gln14-Arg683 |
Immunogen: |
Recombinant SARS-CoV-2 Spike S1 (B.1.1.529/Omicron) Protein is produced by Expi293 cells expression system. The target protein is expressed with sequence (Gln14-Arg683 (A67V, HV69-70del, T95I, G142D, VYY143-145del, N211del, L212I, ins214EPE, G339D, S |
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance